Expanding into a new market is never easy. The challenges of navigating regulations, logistics, supply chain complexities, and finding the right partners can be overwhelming. But for businesses looking to expand between Southeast Asia (SEA) and Europe (EU), the path just became much clearer.
Labgistics Asia is excited to announce a strategic partnership with Kalms Consulting, a leading European consultancy specializing in market entry, regulatory compliance, and business strategy for medical and pharmaceutical companies. This collaboration is designed to support businesses in both regions by providing seamless logistics, regulatory guidance, and market access solutions.
A Partnership Built for Global Growth
Labgistics Asia has long been a trusted partner in 4PL and 3PL logistics, warehousing, and distribution for pharmaceutical, healthcare, and medical device companies. We specialize in helping businesses expand across Southeast Asia by providing the infrastructure and expertise needed to navigate complex supply chains.
Kalms Consulting on the other hand specializes in guiding companies through the complexities of entering and operating in the European market. With extensive experience in regulatory compliance, market entry strategies, and business development, they support businesses in successfully establishing and expanding their presence in Europe.
By combining our strengths, this partnership creates a direct bridge between SEA and Europe, offering businesses a reliable, end-to-end solution for market expansion.
(Image 1)
What This Means for Businesses
For European companies looking to expand into Southeast Asia, Labgistics Asia will provide:
- Logistics and warehousing solutions tailored to the needs of the pharmaceutical and healthcare industries.
- Regulatory guidance and market entry support, ensuring compliance with SEA regulations.
- End-to-end supply chain management, from storage to last-mile delivery.
For Singaporean and Southeast Asian companies entering the European market, Kalms Consulting will offer:
- Regulatory and compliance support to navigate European medical, pharmaceutical, and healthcare market requirements.
- Market entry strategy and business advisory to facilitate successful expansion and operational setup in Europe.
- Access to industry networks and strategic partnerships to connect businesses with key stakeholders and growth opportunities.
This partnership is more than just an exchange of services. By sharing industry insights, exchanging leads, and connecting businesses to the right opportunities, Labgistics Asia and Kalms Consulting are making it easier for companies to expand across borders with confidence.
Stronger Together
As part of this collaboration, both companies will work together to increase exposure in their respective markets. Labgistics Asia will connect with EU companies interested in entering Southeast Asia through 4PL and 3PL logistics models, while Kalms Consulting will help Singaporean businesses navigate the European market.
To support this effort, both companies will engage in a social media exchange, sharing insights on market entry, logistics, and regulatory challenges in both regions. Through regular updates and thought leadership, we aim to provide businesses with the knowledge they need to succeed in new markets.
A New Era of Market Expansion
Breaking into a new market is challenging, but with the right partners and the right strategy, growth becomes achievable. This partnership between Labgistics Asia and Kalms Consulting is about more than just logistics and compliance; it’s about creating opportunities, opening doors, and making global expansion easier for businesses.
For companies looking to expand into Southeast Asia or Europe, this partnership provides the expertise, infrastructure, and connections needed to make the transition seamless.
We’re excited to embark on this journey together, and we look forward to helping businesses navigate the complexities of global expansion.
To learn more about how we can support your market entry Singapore strategy, get in touch with us today.